Monitor the upcoming earnings call for guidance on full-year 2026, particularly regarding the integration of Clario and the impact of strategic collaborations with NVIDIA and SHL Medical on future growth.
Price Chart
Executive Summary
Thermo Fisher Scientific reported strong Q1 2026 results with revenue up 6% to $11.01B and GAAP EPS growing 11% to $4.43, driven by operational excellence and the Clario acquisition. The company raised its dividend by 10% and repurchased $3.0B in stock, signaling confidence in its financial position.
Key Financial Metrics
Key Facts
- Q1 2026 revenue grew 6% YoY to $11.01 billion
- GAAP diluted EPS grew 11% YoY to $4.43
- Adjusted EPS grew 6% YoY to $5.44
- Completed acquisition of Clario, a provider of endpoint data solutions
- Repurchased $3.0 billion of stock and increased dividend by 10%
Financial Impact
Revenue beat consensus by $145M, EPS beat by $1.19
Risk Factors
- Increased debt from the Clario acquisition could impact future financial flexibility
- Integrating Clario may pose operational challenges and cultural integration risks
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0000097745-26-000086 |
| Document: tmo-20260423.htm | 0000097745-26-000086 |
| Document: 0000097745-26-000086-index-headers.html | 0000097745-26-000086 |
| Document: 0000097745-26-000086-index.html | 0000097745-26-000086 |
| Document: 0000097745-26-000086.txt | 0000097745-26-000086 |
| 8-K Data (Synthetic) | 0000097745-26-000086 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 1, 2026 4w ago | Insider Cluster | $600.50 $675.05 | ▲ +12.41% | ▲ +12.30% | $657.28 (+9.46%) |
Aug 26, 2026 5w ago | Insider Cluster | $630.70 $666.33 | ▲ +5.65% | ▲ +5.75% | $657.28 (+4.21%) |
Aug 24, 2026 5w ago | Insider Cluster | $628.74 $658.52 | ▲ +4.74% | ▲ +3.42% | $657.28 (+4.54%) |
Aug 18, 2026 6w ago | Court Ruling | $589.04 $648.43 | ▲ +10.08% | ▲ +11.39% | $657.28 (+11.58%) |
Aug 13, 2026 7w ago | Insider Cluster | $588.29 $613.62 | ▲ +4.31% | ▲ +6.30% | $657.28 (+11.73%) |
Aug 10, 2026 7w ago | Insider Cluster | $605.00 $605.69 | ▲ +0.11% | ▲ +1.17% | $657.28 (+8.64%) |
Aug 7, 2026 8w ago | Insider Cluster | $594.00 $613.78 | ▲ +3.33% | ▲ +3.73% | $657.28 (+10.65%) |
Jul 23, 2026 10w ago | 8-K | $572.32 $627.55 | ▲ +9.65% | ▲ +6.34% | $657.28 (+14.84%) |
Jun 11, 2026 16w ago | ANALYST-UPGRADE | $469.34 $527.05 | ▲ +12.30% | ▲ +10.52% | $657.28 (+40.04%) |
Jun 11, 2026 16w ago | Institutional Cluster | $475.66 $524.71 | ▲ +10.31% | ▲ +8.42% | $657.28 (+38.18%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access